Metabolic

AOD-9604

C-terminal hGH fragment (177–191) historically investigated for lipolysis.

Overview

AOD-9604 is a 16-amino-acid synthetic peptide derived from the lipolytic C-terminal domain of human growth hormone. Reached Phase IIb obesity trials without meeting weight-loss endpoints; later repositioned to cartilage / joint research.

Mechanism

Putative β3-adrenergic mediated lipolysis without GH receptor binding.

Research areas

Obesity (historical)
Cartilage repair

Related peptides

Semaglutide

Long-acting GLP-1 receptor agonist for glycemic control and weight management.

View

Tirzepatide

Dual GIP / GLP-1 receptor agonist with industry-leading weight-loss endpoints.

View

Retatrutide

Investigational triple agonist (GIP / GLP-1 / glucagon) in late-stage trials.

View